The study presents a method to create stable suspension cell lines from 293T cells that produce lentiviral vectors using a single DNA construct, which simplifies the production process compared to the traditional method involving multiple plasmids.
These new cell lines can achieve high yields comparable to those from transient transfection and are designed to be easily scaled up in bioreactors, promoting efficient large-scale production.
By streamlining the production process and improving stability and yield, this approach aims to enhance patient access to therapies developed using lentiviral vectors.